IL-1 Receptor-associated kinase signaling and its role in inflammation, cancer progression and therapy resistance
Chronic inflammation has long been associated with the development of cancer. Amongst the various signaling pathways within cancer cells that can incite the expression of inflammatory molecules are those that activate IL-1 receptor associated kinases (IRAK). The IRAK family comprises of four family...
Main Authors: | Ajay eJain, Sabina eKaczanowska, Eduardo eDavila |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-11-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2014.00553/full |
Similar Items
-
Revisiting Platelets and Toll-Like Receptors (TLRs): At the Interface of Vascular Immunity and Thrombosis
by: Kathryn Hally, et al.
Published: (2020-08-01) -
Toll-like receptors in cerebral ischemic inflammatory injury
by: Yang Qing-Wu, et al.
Published: (2011-10-01) -
Impact of Exercise on Innate Immunity in Multiple Sclerosis Progression and Symptomatology
by: Alison eBarry, et al.
Published: (2016-06-01) -
The Novel Role of Interleukin-1 Receptor-Associated Kinase 1 in the Signaling Process Controlling Innate Immunity and Inflammation
by: Fang, Youjia
Published: (2014) -
Activation of Innate Immunity by Bacterial Ligands of Toll-like Receptors
by: Nelli K. Akhmatova, et al.
Published: (2014-03-01)